Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Regulatory Submissions, Information, and Document Management Forum
Session 3: Artificial Intelligence Panel: Regulatory Affairs in the Age of Artificial Intelligence
Session Chair(s)
Jake Doran
- Head of Digital
- MAPS Public Benefit Corporation (MAPS PBC), United States
Karen McCarthy Schau
- Director, Risk-based Study Management
- Vertex Pharmaceuticals, United States
Thomas Noto
- Senior Director, Regulatory Operations
- Lexicon Pharmaceuticals, United States
In this panel discussion, we will explore how the Regulatory function is positioned in the age of Artificial Intelligence and emerging technologies. From exploring whether it is hype or reality, to evaluating potential use cases, to building business cases, and evaluating organizational readiness for a change of this magnitude; this session will bring together industry leaders to share insight into how Artificial Intelligence will impact Regulatory. As more and more use cases are defined and practical implementation is realized, how will we see the application and impact play out over the next few years?
Learning Objective :
At the conclusion of this session, participants should be able to:
- Understand various use cases for Artificial Intelligence across Regulatory
- Understand the challenges and obstacles organizations face when embarking on exploratory initiatives, such as AI
- Learn about the impact a regulated environment and health authorities will have on adoption of this technology
Speaker(s)
Panelist
Christopher Mundy, MS
- Global Life Sciences Solutions Lead
- Clarivate Analytics, United States
Panelist
Sheila Mahoney Jewels, MBA
- Drug Development Multi-Functionalist
- LifeSciHub , United States
Panelist
Matt Neal, MA
- Senior Director, Regulatory Affairs Operations
- Atara Biotherapuetics, United States
Panelist
Sylva Jana Krizan, PhD, RAC
- Global Compliance, Healthcare and Life Sciences
- Amazon Web Services (AWS), United States
Panelist
Robert Connelly, MBA
- Senior Director, Global Regulatory Operations
- Incyte, United States
Panelist
Steve Gens, MS
- Managing Partner
- Gens & Associates Inc., United States
Contact us
Registration Questions?
Preconference Short Courses
Regulatory Content and Submission Primer: Content from Authoring to Archive
Short Course 1: Data at the Heart of Life Science Professionals: Instant Informed Decision Making
Short Course 2: Preparing and Submitting Standardized Study Data to FDA
Additional Information
Regulatory Affairs and Submissions Resource Kit